Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abacavir/Efavirenz/Didanosine +/- Hydroxyurea in HIV-1 Failing Initial Therapy
NCT00005018Phase 4Completed
- Sponsor
- GSK
- Start
- Jul 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of hydroxyurea in human immunodeficiency virus infection (HIV) (3 arms), sponsored by GSK. Started Jul 1999; status: completed.
02
Drugs
hydroxyurea
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00005018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005018.